Question 1

How many shares of OCUL does ADAGE CAPITAL PARTNERS GP, L.L.C. own?

Accepted Answer

As of 2026-Q2, ADAGE CAPITAL PARTNERS GP, L.L.C. holds 1.6M shares of OCUL (OCULAR THERAPEUTIX INC).

Question 2

What is ADAGE CAPITAL PARTNERS GP, L.L.C.'s OCUL position worth?

Accepted Answer

As of 2026-Q2, ADAGE CAPITAL PARTNERS GP, L.L.C.'s OCUL position is worth $15.2M.

Question 3

Is ADAGE CAPITAL PARTNERS GP, L.L.C. buying or selling OCUL?

Accepted Answer

In 2026-Q2, ADAGE CAPITAL PARTNERS GP, L.L.C. opened a new position in OCUL.

Question 4

When did ADAGE CAPITAL PARTNERS GP, L.L.C. first buy OCUL?

Accepted Answer

Based on available 13F filings, ADAGE CAPITAL PARTNERS GP, L.L.C. first reported a position in OCUL in 2024-Q1. They have held the position across 10 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	1.6M	-	$15.2M	0.0%	$9.82	39
2026-Q1	Exited	0	-100.0%	$0	0.0%	$10.76	0
2025-Q4	Increased	4.6M	+15.5%	$56.1M	0.1%	$12.20	34
2025-Q3	Increased	4M	+2.9%	$46.8M	0.1%	$12.53	30
2025-Q2	Decreased	3.9M	-25.2%	$36.1M	0.1%	$9.22	0
2025-Q1	Increased	5.2M	+44.4%	$38.1M	0.1%	$7.58	39
2024-Q4	Decreased	3.6M	-4.0%	$30.7M	0.1%	$8.35	0
2024-Q3	Increased	3.8M	+1.5%	$32.6M	0.1%	$8.68	29
2024-Q2	Increased	3.7M	+885.4%	$25.3M	0.0%	$6.84	46
2024-Q1	New	375,000	-	$3.4M	0.0%	$9.10	37

OCUL10 quarters

OCUL
10 quarters